Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Monitoring response to tyrosine kinase inhibitor therapy, mutational analysis, and new treatment options in chronic myelogenous leukemiaJerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Treatment milestones in chronic myelogenous leukemia: stay the course or change therapy?Jerald P Radich
Clinical Lymphoma & Myeloma|December 17, 2009
Molecular monitoring of patients with chronic myeloid leukemia: clinical examples from a non-trial settingJerald P Radich
Best Practice & Research. Clinical Haematology|May 4, 2002
Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemiaJerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Monitoring molecular response to tyrosine kinase therapy in chronic myelogenous leukemiaJerald P Radich
Clinical Lymphoma & Myeloma|March 4, 2009
Optimizing timing of secondary tyrosine kinase therapy in chronic myeloid leukemiaJerald P Radich
Cancer|June 7, 2017
Chronic myeloid leukemia: Global impact from a local laboratoryJerald P Radich
Hematology. American Society of Hematology. Education Program|January 18, 2011
Chronic myeloid leukemia 2010: where are we now and where can we go?Jerald P Radich
Hematology. American Society of Hematology. Education Program|November 21, 2007
The Biology of CML blast crisisJerald P Radich
British Journal of Haematology|July 26, 2023
The (near) miracle of therapy in chronic myeloid leukaemiaJerald P Radich
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Monitoring response to tyrosine kinase inhibitor therapy, mutational analysis, and new treatment options in chronic myelogenous leukemiaJerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Treatment milestones in chronic myelogenous leukemia: stay the course or change therapy?Jerald P Radich
Clinical Lymphoma & Myeloma|December 17, 2009
Molecular monitoring of patients with chronic myeloid leukemia: clinical examples from a non-trial settingJerald P Radich
Best Practice & Research. Clinical Haematology|May 4, 2002
Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemiaJerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Monitoring molecular response to tyrosine kinase therapy in chronic myelogenous leukemiaJerald P Radich
Clinical Lymphoma & Myeloma|March 4, 2009
Optimizing timing of secondary tyrosine kinase therapy in chronic myeloid leukemiaJerald P Radich
Cancer|June 7, 2017
Chronic myeloid leukemia: Global impact from a local laboratoryJerald P Radich
Hematology. American Society of Hematology. Education Program|January 18, 2011
Chronic myeloid leukemia 2010: where are we now and where can we go?Jerald P Radich
Hematology. American Society of Hematology. Education Program|November 21, 2007
The Biology of CML blast crisisJerald P Radich
British Journal of Haematology|July 26, 2023
The (near) miracle of therapy in chronic myeloid leukaemiaJerald P Radich
Pageof 21